DNA–chitosan nanoparticles improve DNA vaccine-elicited immunity against Newcastle disease virus through shuttling chicken interleukin-2 gene

References

• Aspden TJ, Mason JD, Jones NS, Lowe J, Skaugrud O, Illum L. Chitosan as a nasal delivery system: the effect of chitosan solutions on in vitro and in vivo mucociliary transport rates in human turbinates and volunteers. J Pharm Sci 1997; 86: 509–13
   PubMed Web of Science ®Google Scholar
• Barouch DH, Letvin NL, Seder RA. The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses. Immunol Rev 2004a; 202: 266–74
   PubMed Web of Science ®Google Scholar
• Barouch DH, Truitt DM, Letvin NL. Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant. Vaccine 2004b; 22: 3092–7
   PubMed Web of Science ®Google Scholar
• Bhagat J, Ahmed KA, Tyagi P, Saxena M, Saxena VK. Effects of supplemental chromium on interferon-gamma (IFN-gamma) mRNA expression in response to Newcastle disease vaccine in broiler chicken. Res Vet Sci 2008; 85: 46–51
   PubMed Web of Science ®Google Scholar
• Erbacher P, Zou S, Bettinger T, Steffan AM, Remy JS. Chitosan-based vector/DNA complexes for gene delivery: biophysical characteristics and transfection ability. Pharm Res 1998; 15: 1332–9
   PubMed Web of Science ®Google Scholar
• Guliyeva U, Oner F, Ozsoy S, Haziroglu R. Chitosan microparticles containing plasmid DNA as potential oral gene delivery system. Eur J Pharm Biopharm 2006; 62: 17–25
   PubMed Web of Science ®Google Scholar
• Hilton LS, Bean AG, Kimpton WG, Lowenthal JW. Interleukin-2 directly induces activation and proliferation of chicken T cells in vivo. J Interferon Cytokine Res 2002; 22: 755–63
   PubMed Web of Science ®Google Scholar
• Hu FQ, Zhao MD, Yuan H, You J, Du YZ, Zeng S. A novel chitosan oligosaccharide-stearic acid micelles for gene delivery: properties and in vitro transfection studies. Int J Pharm 2006; 315: 158–66
   PubMed Web of Science ®Google Scholar
• Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta 2001; 1514: 51–64
   PubMed Web of Science ®Google Scholar
• Jiang W, Jin N, Cui S, Li Z, Zhang L, Wang H, Han W. Enhancing immune responses against HIV-1 DNA vaccine by coinoculating IL-6 expression vector. J Virol Methods 2006; 136: 1–7
   PubMedGoogle Scholar
• Katayose S, Kataoka K. Remarkable increase in nuclease resistance of plasmid DNA through supramolecular assembly with poly(ethylene glycol)-poly(L-lysine) block copolymer. J Pharm Sci 1998; 87: 160–3
   PubMed Web of Science ®Google Scholar
• Li GP, Liu ZG, Liao B, Zhong NS. Induction of Th1-type immune response by chitosan nanoparticles containing plasmid DNA encoding house dust mite allergen Der p 2 for oral vaccination in mice. Cell Mol Immunol 2009; 6: 45–50
   PubMed Web of Science ®Google Scholar
• Loke CF, Omar AR, Raha AR, Yusoff K. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes. Vet Immunol Immunopathol 2005; 106: 259–67
   PubMed Web of Science ®Google Scholar
• Lotze MT, Frana LW, Sharrow SO, Robb RJ, Rosenberg SA. In vivo administration of purified human interleukin 2. I. Half-life and immunologic effects of the Jurkat cell line-derived interleukin 2. J Immunol 1985; 134: 157–66
   Google Scholar
• Maas RA, Komen M, van Diepen M, Oei HL, Claassen IJ. Correlation of haemagglutinin-neuraminidase and fusion protein content with protective antibody response after immunisation with inactivated Newcastle disease vaccines. Vaccine 2003; 21: 3137–42
   PubMed Web of Science ®Google Scholar
• MacLaughlin FC, Mumper RJ, Wang J, Tagliaferri JM, Gill I, Hinchcliffe M, Rolland AP. Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J Control Release 1998; 56: 259–72
   PubMed Web of Science ®Google Scholar
• Mansouri S, Cuie Y, Winnik F, Shi Q, Lavigne P, Benderdour M, Beaumont E, Fernandes JC. Characterization of folate-chitosan-DNA nanoparticles for gene therapy. Biomaterials 2006; 27: 2060–5
   PubMed Web of Science ®Google Scholar
• Mao HQ, Roy K, Troung-Le VL, Janes KA, Lin KY, Wang Y, August JT, Leong KW. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001; 70: 399–421
   PubMed Web of Science ®Google Scholar
• Nishino Y, Niikura M, Suwa T, Onuma M, Gotoh B, Nagai Y, Mikami T. Analysis of the protective effect of the haemagglutinin-neuraminidase protein in Newcastle disease virus infection. J Gen Virol 1991; 72(Pt 5): 1187–90
   PubMedGoogle Scholar
• Park TG, Jeong JH, Kim SW. Current status of polymeric gene delivery systems. Adv Drug Deliv Rev 2006; 58: 467–86
   PubMed Web of Science ®Google Scholar
• Rajesh Kumar S, Ishaq Ahmed VP, Parameswaran V, Sudhakaran R, Sarath Babu V, Sahul Hameed AS. Potential use of chitosan nanoparticles for oral delivery of DNA vaccine in Asian sea bass (Lates calcarifer) to protect from Vibrio (Listonella) anguillarum. Fish Shellfish Immunol 2008; 25: 47–56
   PubMedGoogle Scholar
• Rao SB, Sharma CP. Use of chitosan as a biomaterial: Studies on its safety and hemostatic potential. J Biomed Mater Res 1997; 34: 21–28
   PubMed Web of Science ®Google Scholar
• Richardson SC, Kolbe HV, Duncan R. Potential of low molecular mass chitosan as a DNA delivery system: biocompatibility, body distribution and ability to complex and protect DNA. Int J Pharm 1999; 178: 231–43
   PubMed Web of Science ®Google Scholar
• Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan – DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5: 387–91
   PubMed Web of Science ®Google Scholar
• Sato T, Ishii T, Okahata Y. In vitro gene delivery mediated by chitosan. Effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 2001; 22: 2075–80
   PubMed Web of Science ®Google Scholar
• Scheerlinck JY. Genetic adjuvants for DNA vaccines. Vaccine 2001; 19: 2647–56
   PubMed Web of Science ®Google Scholar
• Stepaniak JA, Shuster JE, Hu W, Sundick RS. Production and in vitro characterization of recombinant chicken interleukin-2. J Interferon Cytokine Res 1999; 19: 515–26
   PubMed Web of Science ®Google Scholar
• Sun CJ, Pan SP, Xie QX, Xiao LJ. Preparation of chitosan-plasmid DNA nanoparticles encoding zona pellucida glycoprotein-3alpha and its expression in mouse. Mol Reprod Dev 2004; 68: 182–8
   PubMedGoogle Scholar
• Sundick RS, Gill-Dixon C. A cloned chicken lymphokine homologous to both mammalian IL-2 and IL-15. J Immunol 1997; 159: 720–5
   PubMed Web of Science ®Google Scholar
• Thiagarajan D, Ram GC, Bansal MP. Optimum conditions for in vitro chicken IL-2 production and its in vivo role in Newcastle disease vaccinated chickens. Vet Immunol Immunopathol 1999; 67: 79–91
   PubMed Web of Science ®Google Scholar
• Wang X, Zhang X, Kang Y, Jin H, Du X, Zhao G, Yu Y, Li J, Su B, Huang C, et al. Interleukin-15 enhance DNA vaccine elicited mucosal and systemic immunity against foot and mouth disease virus. Vaccine 2008; 26: 5135–44
   PubMed Web of Science ®Google Scholar
• Xie Z, Li H, Chen J, Zhang HB, Wang YY, Chen Q, Zhao ZZ, Cheng C, Zhang H, Yang Y, et al. Shuffling of pig interleukin-2 gene and its enhancing of immunity in mice to Pasteurella multocida vaccine. Vaccine 2007; 25: 8163–71
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen J, Li H, Wang Y, Xie Z, Wu M, Zhang H, Zhao Z, Chen Q, Fu M, et al. Porcine interleukin-2 gene encapsulated in chitosan nanoparticles enhances immune response of mice to piglet paratyphoid vaccine. Comp Immunol Microbiol Infect Dis 2007; 30: 19–32
   PubMedGoogle Scholar
• You ZQ, Yu L, Zhang CZ, Li L, Lu MJ, Mao ZJ, Liu Y, Chu WY. Distribution and expression of recombinant plasmid encoding chicken interleukin-2. Vet Res Commun 2007; 31: 273–85
   PubMedGoogle Scholar
• Zhang X, Yu C, Xushi, Zhang C, Tang T, Dai K. Direct chitosan-mediated gene delivery to the rabbit knee joints in vitro and in vivo. Biochem Biophys Res Commun 2006; 341: 202–8
   PubMed Web of Science ®Google Scholar